Literature DB >> 1467633

Coincidence of primary myelodysplastic syndrome and non-Hodgkin lymphoma.

R Schulze1, G Schlimok, D Renner.   

Abstract

A 60-year-old patient is presented with primary myelodysplastic syndrome classified according to the criteria of the French-American-British classification as chronic myelomonocytic leukemia and with a hyperviscosity syndrome. We found a monoclonal gammopathy with a very high serum immunoglobulin M level. There is strong evidence for coincidence of myelodysplastic syndrome and Waldenström's macroglobulinemia in this patient.

Entities:  

Mesh:

Year:  1992        PMID: 1467633     DOI: 10.1007/bf00184549

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  12 in total

1.  Proceedings: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia.

Authors:  W H Knospe; V Loeb; C M Huguley
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

2.  Impaired T-cell and NK-cell function in patients with preleukemia.

Authors:  F Porzsolt; H Heimpel
Journal:  Blut       Date:  1982-10

3.  Chronic myelomonocytic leukemia with paraproteinemia but no detectable plasmacytosis: a detailed cytological and immunological study.

Authors:  D L Barnard; G F Burns; J Gordon; J C Cawley; C R Barker; F G Hayhoe; J L Smith
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

4.  Monoclonal gammopathy in patients with chronic and acute myeloid leukemia.

Authors:  Y Shoenfeld; S Berliner; A Ayalone; M Shaklai; M Djaldetti; A I Pick; J Pinkhas
Journal:  Cancer       Date:  1984-07-15       Impact factor: 6.860

5.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

6.  [Primary myelodysplastic syndrome. Prognostic factors and frequent appearance of monoclonal and polyclonal gammopathies].

Authors:  R von Hirschhausen; J G Saal
Journal:  Dtsch Med Wochenschr       Date:  1990-01-19       Impact factor: 0.628

7.  Decreased T helper cells in the myelodysplastic syndromes.

Authors:  A G Bynoe; C S Scott; P Ford; B E Roberts
Journal:  Br J Haematol       Date:  1983-05       Impact factor: 6.998

8.  Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies.

Authors:  G J Mufti; A Figes; T J Hamblin; D G Oscier; J A Copplestone
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

9.  Immunologic indices in myelodysplastic syndromes.

Authors:  P H Colombat; M Renoux; J P Lamagnere; G Renoux
Journal:  Cancer       Date:  1988-03-15       Impact factor: 6.860

10.  The frequency of M-components in sera of patients with solid malignant neoplasms.

Authors:  A Talerman; W G Haije
Journal:  Br J Cancer       Date:  1973-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.